A Phase I Trial Assessing Lomecel-B Infusion in Individuals with Alzheimer’s Disease: Study Design and Rationale

Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder characterized by memory loss and persistent cognitive dysfunction which significantly compromises quality of life. Brain inflammation is a prominent feature of AD pathology. Lomecel-B which is derived from culture-expanded medici...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdas, Kevin, Yousefi, Keyvan, Hitchinson, Ben, McClain-Moss, Lisa, Diaz, Liliana, Baumel, Barry, Hare, Joshua, Oliva, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969168/
http://dx.doi.org/10.1093/geroni/igab046.2453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969168/
http://dx.doi.org/10.1093/geroni/igab046.2453

Ejemplares similares